Saturated fatty acids and type 2 diabetes: More evidence to re-invent dietary guidelines

The Lancet Diabetes and Endocrinology

Volumn 2, Issue 10, 2014, Pages 770-772

  Mozaffarian, Dariush ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPTADECANOIC ACID; MYRISTIC ACID; PALMITIC ACID; PENTADECANOIC ACID; SATURATED FATTY ACID; STEARIC ACID; UNCLASSIFIED DRUG; FATTY ACID; PHOSPHOLIPID;

DAIRY PRODUCT; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; FAT CONTENT; FAT INTAKE; FATTY ACID BLOOD LEVEL; HUMAN; INCIDENCE; LIPOGENESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; PRACTICE GUIDELINE; TISSUE LEVEL; BLOOD; DIABETES MELLITUS, TYPE 2; FEMALE; MALE;

DIABETES MELLITUS, TYPE 2; FATTY ACIDS; FEMALE; HUMANS; MALE; PHOSPHOLIPIDS;

EID: 84915785471     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(14)70166-4     Document Type: Note

References (10)

1. Mensink RP, Zock PL, Kester AD, Katan MB Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003, 77:1146-1155.
2. Imamura F, Micha R, Wu JHY, et al. Effects of saturated, polyunsaturated, and monounsaturated fat on blood glucose, insulin sensitivity, and beta cell function: a systematic review and meta-analysis of 84 randomized controlled feeding trials. Circulation 2013, 127:A003.
3. Mozaffarian D, Micha R, Wallace S Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2010, 7:e1000252.
4. Chowdhury R, Warnakula S, Kunutsor S, et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med 2014, 160:398-406.
5. Micha R, Mozaffarian D Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids 2010, 45:893-905.
6. Forouhi NG, Koulman A, Sharp SJ, et al. Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study. Lancet Diabetes Endocrinol 2014, published online August 6. http://dx.doi.org/10.1016/S2213-8587(14)70146-9.
7. Mozaffarian D, de Oliveira Otto MC, Lemaitre RN, et al. trans-Palmitoleic acid, other dairy fat biomarkers, and incident diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2013, 97:854-861.
8. Aune D, Norat T, Romundstad P, Vatten LJ Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Am J Clin Nutr 2013, 98:1066-1083.
9. Wu JH, Lemaitre RN, Manichaikul A, et al. Genome-wide association study identifies novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: results from the CHARGE consortium. Circ Cardiovasc Genet 2013, 6:171-183.
10. Khaw KT, Friesen MD, Riboli E, Luben R, Wareham N Plasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: the EPIC-Norfolk prospective study. PLoS Med 2012, 9:e1001255.